150 related articles for article (PubMed ID: 37602452)
1. Long Noncoding RNA MAGI2-AS3 Represses Cell Progression in Clear Cell Renal Cell Carcinoma by Modulating the miR-629-5p/PRDM16 Axis.
Yan C; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Meng B
Crit Rev Eukaryot Gene Expr; 2023; 33(7):43-56. PubMed ID: 37602452
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.
Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T
Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma.
Wang G; Li H; Hou Y
Cancer Gene Ther; 2022 May; 29(5):585-596. PubMed ID: 34002044
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.
Tang C; Cai Y; Jiang H; Lv Z; Yang C; Xu H; Li Z; Li Y
Aging (Albany NY); 2020 Nov; 12(24):25547-25563. PubMed ID: 33231563
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma.
Cao C; Zhou S; Hu J
Int Forum Allergy Rhinol; 2020 Aug; 10(8):1012-1023. PubMed ID: 32450008
[TBL] [Abstract][Full Text] [Related]
6. Role of lncRNA MAGI2-AS3 in lipopolysaccharide-induced nucleus pulposus cells injury by regulating miR-374b-5p/interleukin-10 axis.
Yu J; Li C
Immun Inflamm Dis; 2023 Apr; 11(4):e772. PubMed ID: 37102649
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis.
Yang G; Li T; Liu J; Quan Z; Liu M; Guo Y; Wu Y; Ou L; Wu X; Zheng Y
Genomics; 2023 Mar; 115(2):110599. PubMed ID: 36889366
[TBL] [Abstract][Full Text] [Related]
8. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
Zhang J; Wang R
Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical Cancer by Sponging MiR-15b.
Chai Y; Wang L; Qu Y; Hu Z
J Healthc Eng; 2022; 2022():9707206. PubMed ID: 35126958
[TBL] [Abstract][Full Text] [Related]
10. MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights.
Kortam MA; Elfar N; Shaker OG; El-Boghdady NA; Abd-Elmawla MA
ACS Chem Neurosci; 2023 Mar; 14(6):1107-1118. PubMed ID: 36878000
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
[TBL] [Abstract][Full Text] [Related]
12. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
Chang H; Zhang X; Li B; Meng X
Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706
[TBL] [Abstract][Full Text] [Related]
13. Role of MAGI2-AS3 in malignant and non-malignant disorders.
Taheri M; Askari A; Hussen BM; Ghafouri-Fard S; Rashnoo F
Pathol Res Pract; 2023 Jun; 246():154530. PubMed ID: 37196468
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding MAGI2-AS3 Suppresses Several Cellular Processes of Lung Squamous Cell Carcinoma Cells by Regulating miR-374a/b-5p/CADM2 Axis.
He J; Zhou X; Li L; Han Z
Cancer Manag Res; 2020; 12():289-302. PubMed ID: 32021443
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25.
Sui Y; Chi W; Feng L; Jiang J
BMC Pulm Med; 2020 Mar; 20(1):59. PubMed ID: 32138716
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis.
Gong J; Ma L; Peng C; Liu J
Ann Transl Med; 2021 Dec; 9(24):1793. PubMed ID: 35071487
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MAGI2-AS3 Inhibits Prostate Cancer Progression by Targeting the miR-142-3p.
Hu R; Wu P; Liu J
Horm Metab Res; 2022 Nov; 54(11):754-759. PubMed ID: 35944561
[TBL] [Abstract][Full Text] [Related]
18. Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC.
Wang C; Su K; Lin H; Cen B; Zheng S; Xu X
Cells; 2022 Nov; 11(21):. PubMed ID: 36359865
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.
Wang F; Zu Y; Zhu S; Yang Y; Huang W; Xie H; Li G
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):231-235. PubMed ID: 30442369
[TBL] [Abstract][Full Text] [Related]
20.
Liu Q; Lei C
Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
